{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:53:30Z","timestamp":1791143610642,"version":"4.1.0"},"reference-count":163,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.mehy.2011.06.029","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T00:03:43Z","timestamp":1311465823000},"page":"550-556","source":"Crossref","is-referenced-by-count":25,"title":["Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"77","author":[{"given":"Mark F.","family":"McCarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.mehy.2011.06.029_b0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1301\/002966402320387224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants","volume":"60","author":"Mehta","year":"2002","journal-title":"Nutr Rev"},{"issue":"9","key":"10.1016\/j.mehy.2011.06.029_b0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jnutbio.2007.10.001","article-title":"The role of fatty acids in the development and progression of nonalcoholic fatty liver disease","volume":"19","author":"Gentile","year":"2008","journal-title":"J Nutr Biochem"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2011.06.029_b0015","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1440-1746.2006.04640.x","article-title":"Role of mitochondria in non-alcoholic fatty liver disease","volume":"22","author":"Pessayre","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"22","key":"10.1016\/j.mehy.2011.06.029_b0020","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2174\/092986710791698530","article-title":"Targeting mitochondria: a new promising approach for the treatment of liver diseases","volume":"17","author":"Serviddio","year":"2010","journal-title":"Curr Med Chem"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","article-title":"Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model","volume":"52","author":"Rector","year":"2010","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2011.06.029_b0030","first-page":"S98","article-title":"Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex","volume":"23","author":"De","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0035","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/hep.20719","article-title":"NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells","volume":"41","author":"Adachi","year":"2005","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.mehy.2011.06.029_b0040","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI18212","article-title":"NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis","volume":"112","author":"Bataller","year":"2003","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0045","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.21375","article-title":"Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice","volume":"44","author":"Choi","year":"2006","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.mehy.2011.06.029_b0050","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","article-title":"Review: the role of insulin resistance in nonalcoholic fatty liver disease","volume":"91","author":"Utzschneider","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-0028-1091985","article-title":"Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery","volume":"28","author":"Verna","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"Suppl 2","key":"10.1016\/j.mehy.2011.06.029_b0060","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1007\/s001250051435","article-title":"The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoB","volume":"40","author":"Sniderman","year":"1997","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1079\/PNS200195","article-title":"Adipose tissue and the insulin resistance syndrome","volume":"60","author":"Frayn","year":"2001","journal-title":"Proc Nutr Soc"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0306-9877(95)90258-9","article-title":"Optimizing exercise for fat loss","volume":"44","author":"McCarty","year":"1995","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0075","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.mehy.2008.09.063","article-title":"A \u201cmini-fast with exercise\u201d protocol for fat loss","volume":"73","author":"McCarty","year":"2009","journal-title":"Med Hypotheses"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0080","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/MCO.0b013e328312c353","article-title":"Nonalcoholic fatty liver disease: the potential role of nutritional management","volume":"11","author":"Leclercq","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0085","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1053\/jhep.2003.50132","article-title":"Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis","volume":"37","author":"Musso","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MOG.0b013e3283358a58","article-title":"Implications of diet on nonalcoholic fatty liver disease","volume":"26","author":"Sullivan","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","article-title":"The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome","volume":"7","author":"Lim","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0100","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0105","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2009.05.033","article-title":"Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome","volume":"51","author":"Abid","year":"2009","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ajcn\/84.1.136","article-title":"Dietary glycemic index and liver steatosis","volume":"84","author":"Valtuena","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ajcn\/84.1.3","article-title":"Nonalcoholic fatty liver, nonalcoholic steatohepatitis, ectopic fat, and the glycemic index","volume":"84","author":"Jenkins","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MCO.0b013e328302f3ec","article-title":"Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease","volume":"11","author":"Le","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"7","key":"10.1016\/j.mehy.2011.06.029_b0125","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2337\/diacare.18.7.962","article-title":"Physiological modulation of plasma free fatty acid concentrations by diet. Metabolic implications in nondiabetic subjects","volume":"18","author":"Wolever","year":"1995","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0130","doi-asserted-by":"crossref","first-page":"1588S","DOI":"10.3945\/ajcn.2009.26736H","article-title":"A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial","volume":"89","author":"Barnard","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1753-4887.2009.00198.x","article-title":"Vegetarian and vegan diets in type 2 diabetes management","volume":"67","author":"Barnard","year":"2009","journal-title":"Nutr Rev"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcn\/70.3.353","article-title":"Dietary intake and iron status of Australian vegetarian women","volume":"70","author":"Ball","year":"1999","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0145","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ajcn\/67.4.722","article-title":"Dietary determinants of iron stores in a free-living elderly population: the Framingham heart study","volume":"67","author":"Fleming","year":"1998","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.20012","article-title":"A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis","volume":"39","author":"Promrat","year":"2004","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.mehy.2011.06.029_b0155","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1542-3565(04)00457-4","article-title":"A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis","volume":"2","author":"Sanyal","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"22","key":"10.1016\/j.mehy.2011.06.029_b0160","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0165","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.mehy.2011.06.029_b0170","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.mehy.2011.06.029_b0175","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0180","doi-asserted-by":"crossref","first-page":"E405","DOI":"10.1152\/ajpendo.00378.2004","article-title":"PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice. Role for NADPH oxidase","volume":"288","author":"Talior","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0185","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.atherosclerosis.2009.10.012","article-title":"Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia","volume":"209","author":"Yoshida","year":"2010","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0190","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/jcb.21583","article-title":"Astaxanthin protects mesangial cells from hyperglycemia-induced oxidative signaling","volume":"103","author":"Manabe","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.mehy.2011.06.029_b0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000212745","article-title":"Astaxanthin protects neuronal cells against oxidative damage and is a potent candidate for brain food","volume":"61","author":"Liu","year":"2009","journal-title":"Forum Nutr"},{"key":"10.1016\/j.mehy.2011.06.029_b0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2008.11.076","article-title":"Astaxanthin inhibits reactive oxygen species-mediated cellular toxicity in dopaminergic SH-SY5Y cells via mitochondria-targeted protective mechanism","volume":"1254","author":"Liu","year":"2009","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jnutbio.2009.01.011","article-title":"Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress","volume":"21","author":"Wolf","year":"2010","journal-title":"J Nutr Biochem"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0210","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1089\/jmf.2007.621","article-title":"Clinical potential of Spirulina as a source of phycocyanobilin","volume":"10","author":"McCarty","year":"2007","journal-title":"J Med Food"},{"issue":"13","key":"10.1016\/j.mehy.2011.06.029_b0215","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1096\/fj.04-2368fje","article-title":"Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats","volume":"19","author":"Lanone","year":"2005","journal-title":"FASEB J"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2011.06.029_b0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11010-006-9190-y","article-title":"Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction","volume":"291","author":"Matsumoto","year":"2006","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0225","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/01.HYP.0000242336.58387.1f","article-title":"NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells","volume":"48","author":"Jiang","year":"2006","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0230","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/HYPERTENSIONAHA.107.092296","article-title":"Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress","volume":"50","author":"Datla","year":"2007","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0235","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4162\/nrp.2008.2.4.295","article-title":"A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients","volume":"2","author":"Lee","year":"2008","journal-title":"Nutr Res Pract"},{"issue":"8","key":"10.1016\/j.mehy.2011.06.029_b0240","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.mehy.2011.06.029_b0245","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.2337\/diabetes.51.8.2420","article-title":"The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism","volume":"51","author":"Hawley","year":"2002","journal-title":"Diabetes"},{"issue":"46","key":"10.1016\/j.mehy.2011.06.029_b0250","doi-asserted-by":"crossref","first-page":"47898","DOI":"10.1074\/jbc.M408149200","article-title":"AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells","volume":"279","author":"Zang","year":"2004","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"10.1016\/j.mehy.2011.06.029_b0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1113\/jphysiol.2006.108506","article-title":"Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders","volume":"574","author":"Viollet","year":"2006","journal-title":"J Physiol"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0260","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1572-0241.2005.41583.x","article-title":"A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease","volume":"100","author":"Bugianesi","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0265","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1665-2681(19)31902-7","article-title":"Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions","volume":"6","author":"Duseja","year":"2007","journal-title":"Ann Hepatol"},{"issue":"8","key":"10.1016\/j.mehy.2011.06.029_b0270","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ijo.2010.40","article-title":"Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study","volume":"34","author":"Garinis","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.mehy.2011.06.029_b0275","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/831901","article-title":"Long-term effects of metformin and lifestyle modification on nonalcoholic Fatty liver disease obese adolescents","author":"Tock","year":"2010","journal-title":"J Obes"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0280","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0306-9877(94)90120-1","article-title":"Promotion of hepatic lipid oxidation and gluconeogenesis as a strategy for appetite control","volume":"42","author":"McCarty","year":"1994","journal-title":"Med Hypotheses"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0285","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1054\/mehy.2000.1322","article-title":"Hepatothermic therapy of obesity: rationale and an inventory of resources","volume":"57","author":"McCarty","year":"2001","journal-title":"Med Hypotheses"},{"issue":"10","key":"10.1016\/j.mehy.2011.06.029_b0290","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s11745-006-1156-z","article-title":"The hypotriglyceridemic effect of dietary n-3 FA is associated with increased beta-oxidation and reduced leptin expression","volume":"38","author":"Ukropec","year":"2003","journal-title":"Lipids"},{"issue":"7","key":"10.1016\/j.mehy.2011.06.029_b0295","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02578245","article-title":"Effect of dietary n-3 and n-6 polyunsaturated fatty acids on lipid-metabolizing enzymes in obese rat liver","volume":"29","author":"Niot","year":"1994","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000046703","article-title":"Effects of long-chain monounsaturated and n-3 fatty acids on fatty acid oxidation and lipid composition in rats","volume":"45","author":"Halvorsen","year":"2001","journal-title":"Ann Nutr Metab"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0305","doi-asserted-by":"crossref","first-page":"E969","DOI":"10.1152\/ajpendo.00497.2007","article-title":"A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels","volume":"294","author":"Stefanovic-Racic","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0310","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/ajg.2009.719","article-title":"l-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis\u2013a randomized and controlled clinical trial","volume":"105","author":"Malaguarnera","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0315","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.dld.2007.10.003","article-title":"Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease","volume":"40","author":"Spadaro","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0320","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1203\/01.PDR.0000153672.43030.75","article-title":"Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease","volume":"57","author":"Alwayn","year":"2005","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0325","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.clnu.2010.06.001","article-title":"The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease","volume":"30","author":"Shapiro","year":"2011","journal-title":"Clin Nutr"},{"issue":"10","key":"10.1016\/j.mehy.2011.06.029_b0330","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/MEG.0b013e32833b257a","article-title":"Treatment with Omega-3 fatty acids but not exendin-4 improves hepatic steatosis","volume":"22","author":"Bulchandani","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0335","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/ajcn\/76.6.1302","article-title":"The metabolic response to ingested glycine","volume":"76","author":"Gannon","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0340","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0022-3565(24)37682-7","article-title":"Glycine accelerates recovery from alcohol-induced liver injury","volume":"286","author":"Yin","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"9\u201310","key":"10.1016\/j.mehy.2011.06.029_b0345","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s000180050030","article-title":"Glycine: a new anti-inflammatory immunonutrient","volume":"56","author":"Wheeler","year":"1999","journal-title":"Cell Mol Life Sci"},{"issue":"11 Suppl","key":"10.1016\/j.mehy.2011.06.029_b0350","doi-asserted-by":"crossref","first-page":"162S","DOI":"10.1097\/01.alc.0000189281.82523.6c","article-title":"Glycine as a therapeutic immuno-nutrient for alcoholic liver disease","volume":"29","author":"Yamashina","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0355","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000282083","article-title":"The role of cytokines in non-alcoholic fatty liver disease","volume":"28","author":"Tilg","year":"2010","journal-title":"Dig Dis"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0360","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.mehy.2004.01.040","article-title":"High mitochondrial redox potential may promote induction and activation of UCP2 in hepatocytes during hepatothermic therapy","volume":"64","author":"McCarty","year":"2005","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0365","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00004836-198704000-00019","article-title":"Effect of rapid weight loss with supplemented fasting on liver tests","volume":"9","author":"Friis","year":"1987","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0370","first-page":"97","article-title":"Effects of total fasting in obese women. II. Acid-base balance","volume":"71","author":"Sonka","year":"1978","journal-title":"Endokrinologie"},{"issue":"10","key":"10.1016\/j.mehy.2011.06.029_b0375","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0026-0495(80)90037-2","article-title":"Protective effect of small amounts of glucose on abnormal liver function tests during starvation","volume":"29","author":"Abraira","year":"1980","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0380","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2036.2010.04405.x","article-title":"Pioglitazone in the treatment of NASH: the role of adiponectin","volume":"32","author":"Gastaldelli","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.mehy.2011.06.029_b0385","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0390","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0395","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/hep.21995","article-title":"Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells","volume":"47","author":"Caligiuri","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0400","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.21991","article-title":"High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase","volume":"47","author":"Adachi","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0405","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/jcb.22634","article-title":"Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3)","volume":"110","author":"Handy","year":"2010","journal-title":"J Cell Biochem"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0410","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1271\/bbb.60521","article-title":"Effects of astaxanthin in obese mice fed a high-fat diet","volume":"71","author":"Ikeuchi","year":"2007","journal-title":"Biosci Biotechnol Biochem"},{"issue":"7","key":"10.1016\/j.mehy.2011.06.029_b0415","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1172\/JCI9020","article-title":"NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease","volume":"106","author":"Kono","year":"2000","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0420","doi-asserted-by":"crossref","first-page":"G1005","DOI":"10.1152\/ajpgi.2001.280.5.G1005","article-title":"Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat","volume":"280","author":"Kono","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2011.06.029_b0425","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1111\/j.1440-1746.2006.04650.x","article-title":"Regulation of macrophage activation in alcoholic liver disease","volume":"22","author":"Thakur","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.mehy.2011.06.029_b0430","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.MP.0000019579.30842.96","article-title":"Kupffer cell aggregation and perivenular distribution in steatohepatitis","volume":"15","author":"Lefkowitch","year":"2002","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0435","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","article-title":"Kupffer cells in non-alcoholic fatty liver disease: the emerging view","volume":"51","author":"Baffy","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.mehy.2011.06.029_b0440","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1752-1947-4-103","article-title":"Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series","volume":"4","author":"Ferreira-Hermosillo","year":"2010","journal-title":"J Med Case Reports"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0445","first-page":"787","article-title":"Spirulina maxima prevents induction of fatty liver by carbon tetrachloride in the rat","volume":"44","author":"Torres-Duran","year":"1998","journal-title":"Biochem Mol Biol Int"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0450","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0024-3205(93)90611-6","article-title":"Preventive effect of Spirulina maxima on the fatty liver induced by a fructose-rich diet in the rat, a preliminary report","volume":"53","author":"Gonzalez de","year":"1993","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0455","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-8741(98)00120-2","article-title":"Studies on the preventive effect of Spirulina maxima on fatty liver development induced by carbon tetrachloride, in the rat","volume":"64","author":"Torres-Duran","year":"1999","journal-title":"J Ethnopharmacol"},{"issue":"22","key":"10.1016\/j.mehy.2011.06.029_b0460","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/S0024-3205(02)01512-6","article-title":"Arthrospira maxima prevents the acute fatty liver induced by the administration of simvastatin, ethanol and a hypercholesterolemic diet to mice","volume":"70","author":"Ble-Castillo","year":"2002","journal-title":"Life Sci"},{"issue":"9","key":"10.1016\/j.mehy.2011.06.029_b0465","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0024-3205(01)01185-7","article-title":"Spirulina maxima prevents fatty liver formation in CD-1 male and female mice with experimental diabetes","volume":"69","author":"Rodriguez-Hernandez","year":"2001","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0470","first-page":"77","article-title":"Efficacy of using alpha-lipoic acid (berlition) in patients with nonalcoholic steatohepatitis","author":"Podymova","year":"2008","journal-title":"Eksp Klin Gastroenterol"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0475","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.21313","article-title":"Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob\/ob mice","volume":"44","author":"Garcia-Ruiz","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0480","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1021\/pr9011427","article-title":"Mitochondrial complex I subunits are decreased in murine nonalcoholic fatty liver disease: implication of peroxynitrite","volume":"9","author":"Garcia-Ruiz","year":"2010","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphotobiol.2007.04.007","article-title":"Lutein, zeaxanthin and astaxanthin protect against DNA damage in SK-N-SH human neuroblastoma cells induced by reactive nitrogen species","volume":"88","author":"Santocono","year":"2007","journal-title":"J Photochem Photobiol B"},{"issue":"10","key":"10.1016\/j.mehy.2011.06.029_b0490","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1271\/bbb.80358","article-title":"Reaction of astaxanthin with peroxynitrite","volume":"72","author":"Hayakawa","year":"2008","journal-title":"Biosci Biotechnol Biochem"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0495","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0014-5793(03)01358-9","article-title":"Van d, V, Bast A. Tetrahydrofolate and 5-methyltetrahydrofolate are folates with high antioxidant activity. Identification of the antioxidant pharmacophore","volume":"555","author":"Rezk","year":"2003","journal-title":"FEBS Lett"},{"issue":"11","key":"10.1016\/j.mehy.2011.06.029_b0500","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/CIRCULATIONAHA.106.612325","article-title":"5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling","volume":"114","author":"Antoniades","year":"2006","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0505","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.mehy.2008.09.058","article-title":"High-dose folate and dietary purines promote scavenging of peroxynitrite-derived radicals\u2013clinical potential in inflammatory disorders","volume":"73","author":"McCarty","year":"2009","journal-title":"Med Hypotheses"},{"issue":"11","key":"10.1016\/j.mehy.2011.06.029_b0510","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1055\/s-0030-1263122","article-title":"Dietary Folic Acid Activates AMPK and Improves Insulin Resistance and Hepatic Inflammation in Dietary Rodent Models of the Metabolic Syndrome","volume":"42","author":"Buettner","year":"2010","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0515","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/135245850100700507","article-title":"Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease","volume":"7","author":"Spitsin","year":"2001","journal-title":"Mult Scler"},{"issue":"25","key":"10.1016\/j.mehy.2011.06.029_b0520","doi-asserted-by":"crossref","first-page":"16303","DOI":"10.1073\/pnas.212645999","article-title":"Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors","volume":"99","author":"Scott","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0525","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/acm.2008.0513","article-title":"The treatment of multiple sclerosis with inosine","volume":"15","author":"Markowitz","year":"2009","journal-title":"J Altern Complement Med"},{"issue":"13","key":"10.1016\/j.mehy.2011.06.029_b0530","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1055\/s-0028-1088302","article-title":"Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals","volume":"74","author":"Surh","year":"2008","journal-title":"Planta Med"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0535","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbrc.2003.09.110","article-title":"Induction of endogenous antioxidants and phase 2 enzymes by alpha-lipoic acid in rat cardiac H9C2 cells: protection against oxidative injury","volume":"310","author":"Cao","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0540","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s11064-007-9496-5","article-title":"Potent upregulation of glutathione and NAD(P)H:quinone oxidoreductase 1 by alpha-lipoic acid in human neuroblastoma SH-SY5Y cells: protection against neurotoxicant-elicited cytotoxicity","volume":"33","author":"Jia","year":"2008","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1600-079X.2003.00092.x","article-title":"Regulation of antioxidant enzymes: a significant role for melatonin","volume":"36","author":"Rodriguez","year":"2004","journal-title":"J Pineal Res"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0550","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/BF02253360","article-title":"Actions of melatonin in the reduction of oxidative stress. A review","volume":"7","author":"Reiter","year":"2000","journal-title":"J Biomed Sci"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0555","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetylcysteine\u2013a safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr Opin Pharmacol"},{"issue":"12","key":"10.1016\/j.mehy.2011.06.029_b0560","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14728220802517901","article-title":"N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility","volume":"8","author":"Dodd","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0565","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/hep.22496","article-title":"Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways","volume":"48","author":"Park","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0570","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.abb.2009.01.024","article-title":"Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion","volume":"485","author":"Butler","year":"2009","journal-title":"Arch Biochem Biophys"},{"issue":"2\u20133","key":"10.1016\/j.mehy.2011.06.029_b0575","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2007.06.011","article-title":"Melatonin treatment improves the antioxidant status and decreases lipid content in brain and liver of rats","volume":"571","author":"Subramanian","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0580","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-079X.2006.00346.x","article-title":"Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats","volume":"41","author":"Pan","year":"2006","journal-title":"J Pineal Res"},{"issue":"4","key":"10.1016\/j.mehy.2011.06.029_b0585","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1600-079X.2009.00676.x","article-title":"Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats","volume":"46","author":"Tahan","year":"2009","journal-title":"J Pineal Res"},{"issue":"38","key":"10.1016\/j.mehy.2011.06.029_b0590","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.3748\/wjg.v13.i38.5127","article-title":"N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis","volume":"13","author":"Thong-Ngam","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0595","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1872-034X.2007.00215.x","article-title":"Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis","volume":"38","author":"de Oliveira","year":"2008","journal-title":"Hepatol Res"},{"issue":"10","key":"10.1016\/j.mehy.2011.06.029_b0600","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/jn\/138.10.1872","article-title":"N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis","volume":"138","author":"Baumgardner","year":"2008","journal-title":"J Nutr"},{"issue":"23","key":"10.1016\/j.mehy.2011.06.029_b0605","doi-asserted-by":"crossref","first-page":"16020","DOI":"10.1074\/jbc.274.23.16020","article-title":"Flux of the L-serine metabolism in rat liver. The predominant contribution of serine dehydratase","volume":"274","author":"Xue","year":"1999","journal-title":"J Biol Chem"},{"issue":"1 Pt. 1","key":"10.1016\/j.mehy.2011.06.029_b0610","doi-asserted-by":"crossref","first-page":"C227","DOI":"10.1152\/ajpcell.1995.268.1.C227","article-title":"Alpha-Ketoacids scavenge H2O2 in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity","volume":"268","author":"Nath","year":"1995","journal-title":"Am J Physiol"},{"issue":"9","key":"10.1016\/j.mehy.2011.06.029_b0615","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.nut.2006.05.009","article-title":"Is pyruvate an endogenous anti-inflammatory molecule?","volume":"22","author":"Das","year":"2006","journal-title":"Nutrition"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0620","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1067\/mpd.2000.106566","article-title":"Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study","volume":"136","author":"Lavine","year":"2000","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0625","first-page":"124","article-title":"Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment","volume":"16","author":"Ersoz","year":"2005","journal-title":"Turk J Gastroenterol"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0630","first-page":"251","article-title":"Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease","volume":"24","author":"Madan","year":"2005","journal-title":"Indian J Gastroenterol"},{"issue":"12","key":"10.1016\/j.mehy.2011.06.029_b0635","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s10620-006-9359-y","article-title":"The restorative effect of taurine on experimental nonalcoholic steatohepatitis","volume":"51","author":"Chen","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mehy.2011.06.029_b0640","series-title":"Vallerand D","author":"Haddad","year":"2009"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0645","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1124\/jpet.109.161612","article-title":"A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis","volume":"332","author":"Serviddio","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0650","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1349-7006.2008.01001.x","article-title":"Role of iron in carcinogenesis: cancer as a ferrotoxic disease","volume":"100","author":"Toyokuni","year":"2009","journal-title":"Cancer Sci"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0655","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/ajcn\/87.5.1374","article-title":"Pathways underlying iron accumulation in human nonalcoholic fatty liver disease","volume":"87","author":"Aigner","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0660","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.20023","article-title":"Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver","volume":"39","author":"Bugianesi","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0665","first-page":"432","article-title":"Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease","volume":"47","author":"Moon","year":"2006","journal-title":"Korean J Gastroenterol"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0670","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1572-0241.2007.01192.x","article-title":"Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study","volume":"102","author":"Valenti","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gcb.2009.07.032","article-title":"Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis","volume":"34","author":"Nahon","year":"2010","journal-title":"Gastroenterol Clin Biol"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0680","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1158\/1055-9965.EPI-08-0725","article-title":"Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis","volume":"18","author":"Fujita","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.mehy.2011.06.029_b0685","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00535-007-2095-z","article-title":"Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C","volume":"42","author":"Kato","year":"2007","journal-title":"J Gastroenterol"},{"issue":"14","key":"10.1016\/j.mehy.2011.06.029_b0690","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/jnci\/djn209","article-title":"Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial","volume":"100","author":"Zacharski","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0695","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1349-7006.2009.01394.x","article-title":"Body iron store as a predictor of oxidative DNA damage in healthy men and women","volume":"101","author":"Hori","year":"2010","journal-title":"Cancer Sci"},{"issue":"5174","key":"10.1016\/j.mehy.2011.06.029_b0700","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"issue":"6706","key":"10.1016\/j.mehy.2011.06.029_b0705","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.mehy.2011.06.029_b0710","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.2337\/diabetes.54.12.3458","article-title":"Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver","volume":"54","author":"Boden","year":"2005","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0715","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1677\/JOE-07-0005","article-title":"Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo","volume":"195","author":"Park","year":"2007","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0720","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.diabres.2010.04.004","article-title":"Salicylate prevents hepatic oxidative stress activation caused by short-term elevation of free fatty acids in vivo","volume":"89","author":"He","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0725","first-page":"49","article-title":"Effect of sodium salicylate on oxidative stress and insulin resistance induced by free fatty acids","volume":"9","author":"He","year":"2010","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"50","key":"10.1016\/j.mehy.2011.06.029_b0730","doi-asserted-by":"crossref","first-page":"48115","DOI":"10.1074\/jbc.M209459200","article-title":"Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex","volume":"277","author":"Gao","year":"2002","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.mehy.2011.06.029_b0735","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.intimp.2008.05.004","article-title":"Expression of NADPH oxidases and enhanced H(2)O(2)-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-alpha","volume":"8","author":"Yoshida","year":"2008","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"10.1016\/j.mehy.2011.06.029_b0740","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1074\/jbc.M506172200","article-title":"NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox","volume":"281","author":"Anrather","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0745","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1189\/jlb.1206735","article-title":"Role of NF-kappaB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-alpha","volume":"82","author":"Gauss","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"4\u20135","key":"10.1016\/j.mehy.2011.06.029_b0750","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/13813450701531235","article-title":"Regulation of NADPH oxidase subunit p22(phox) by NF-kB in human aortic smooth muscle cells","volume":"113","author":"Manea","year":"2007","journal-title":"Arch Physiol Biochem"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0755","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0760","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.mehy.2011.06.029_b0765","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI30400","article-title":"Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease","volume":"117","author":"Samuel","year":"2007","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.mehy.2011.06.029_b0770","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1074\/jbc.275.12.9047","article-title":"The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)","volume":"275","author":"Aguirre","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0775","first-page":"80","article-title":"Salsalate: its role in the management of rheumatic disease","volume":"3","author":"Singleton","year":"1980","journal-title":"Clin Ther"},{"issue":"11","key":"10.1016\/j.mehy.2011.06.029_b0780","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/jps.2600731147","article-title":"Metabolism of salsalate in normal subjects","volume":"73","author":"Dromgoole","year":"1984","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0785","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2337\/dc07-1338","article-title":"Salsalate improves glycemia and inflammatory parameters in obese young adults","volume":"31","author":"Fleischman","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.mehy.2011.06.029_b0790","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1752-8062.2008.00026.x","article-title":"Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes","volume":"1","author":"Goldfine","year":"2008","journal-title":"Clin Transl Sci"},{"issue":"6","key":"10.1016\/j.mehy.2011.06.029_b0795","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial","volume":"152","author":"Goldfine","year":"2010","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.mehy.2011.06.029_b0800","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00002018-199309020-00006","article-title":"Ototoxicity associated with salicylates. A brief review","volume":"9","author":"Brien","year":"1993","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.mehy.2011.06.029_b0805","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0149-2918(95)80061-1","article-title":"Assessment of salsalate, a nonacetylated salicylate, in the treatment of patients with arthritis","volume":"17","author":"Atkinson","year":"1995","journal-title":"Clin Ther"},{"issue":"9","key":"10.1016\/j.mehy.2011.06.029_b0810","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.108.804294","article-title":"Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight\/obese middle-aged and older humans","volume":"119","author":"Pierce","year":"2009","journal-title":"Circulation"},{"issue":"28","key":"10.1016\/j.mehy.2011.06.029_b0815","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1073\/pnas.0603499103","article-title":"Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation","volume":"103","author":"Sakurai","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711002878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711002878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T08:42:41Z","timestamp":1741336961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987711002878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":163,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0306987711002878"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2011.06.029","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}